Press release
Aquestive Therapeutics, Inc. (NASDAQ: AQST) Investor Notice: Update in Lawsuit announced
A lawsuit is pending for certain investors in investors in Aquestive Therapeutics, Inc. (NASDAQ: AQST) shares.
If you purchased shares of Aquestive Therapeutics, Inc. (NASDAQ: AQST), you have certain options and you should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
On March 1, 2021, a lawsuit was filed against Aquestive Therapeutics, Inc. over alleged violations of Federal Securities Laws. The plaintiff claims that between December 2, 2019 and September 25, 2020, the Defendants made materially false and misleading statements regarding the Company's business, operational and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that data included in the Libervant NDA submission showed a lower drug exposure level than desired for certain weight groups, that the foregoing significantly decreased the Libervant NDA's approval prospects, that as a result, it was foreseeable that the FDA would not approve the Libervant NDA in its current form, and that as a result, the Company's public statements were materially false and misleading at all relevant times.
On June 25, 2021, an amended complaint was filed and on August 16, 2021, the defendants filed their motion to dismiss the case.
Those who purchased shares of Aquestive Therapeutics, Inc. (NASDAQ: AQST) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Aquestive Therapeutics, Inc. (NASDAQ: AQST) Investor Notice: Update in Lawsuit announced here
News-ID: 2709163 • Views: …
More Releases from Shareholders Foundation
Lawsuit for Investors in Sonder Holdings Inc. (NASDAQ: SOND) filed in effort to …
An investor, who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND), filed a lawsuit over alleged violations of Federal Securities Laws by Sonder Holdings Inc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: SOND investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
Lawsuit filed for Investors in Ocugen, Inc. (NASDAQ: OCGN) in effort to recover …
An investor, who purchased shares of Ocugen, Inc. (NASDAQ: OCGN), filed a lawsuit i over alleged violations of Federal Securities Laws by Ocugen, Inc..
Investors who purchased shares of Ocugen, Inc. (NASDAQ: OCGN) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: OCGN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Malvern, PA based Ocugen, Inc., a…
Investors who lost money with shares of Evolv Technologies Holdings, Inc. (NASDA …
An investor, who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV), filed a lawsuit in the U.S. District Court for the District of Massachusetts over alleged violations of Federal Securities Laws by Evolv Technologies Holdings, Inc. f/k/a NewHold Investment Corp.
Investors who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) have certain options and for certain investors are short and strict deadlines running. Deadline: May 24, 2024. NASDAQ: EVLV…
Investigation announced for Investors who purchased shares of Comtech Telecommun …
Comtech Telecommunications Corp is under investigation over potential securities laws violations in connection with certain financial statements.
Investors who purchased shares of Comtech Telecommunications Corp. (NASDAQ: CMTL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Comtech Telecommunications Corp. regarding its business, its prospects and its operations were materially false…
More Releases for Aquestive
Investigation announced for Investors in Aquestive Therapeutics, Inc. (NASDAQ: A …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Aquestive Therapeutics, Inc.
Investors who purchased shares of Aquestive Therapeutics, Inc. (NASDAQ: AQST) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Aquestive Therapeutics, Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders.
On…
Investigation announced for Long-Term Investors in shares of Aquestive Therapeut …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Aquestive Therapeutics, Inc.
Investors who purchased shares of Aquestive Therapeutics, Inc. (NASDAQ: AQST) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Aquestive Therapeutics, Inc. (NASDAQ: AQST officers and directors breached their fiduciary duties and caused damage to the…
Aquestive Therapeutics, Inc. (NASDAQ: AQST) Investor Notice: Update in Lawsuit
The Shareholders Foundation announced an update in the lawsuit that is pending for certain investors in , shares of Aquestive Therapeutics, Inc. (NASDAQ: AQST over alleged violations of Federal Securities Laws by Aquestive Therapeutics, Inc.
If you purchased shares of Aquestive Therapeutics, Inc. (NASDAQ: AQST), you have certain options and you should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
On March 1, 2021, a lawsuit was filed…
Investigation announced for Long-Term Investors in Aquestive Therapeutics, Inc. …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Aquestive Therapeutics, Inc..
Investors who are current long term investors in Aquestive Therapeutics, Inc. (NASDAQ: AQST) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: AQST stocks follows a lawsuit filed against…
Deadline on April 30, 2021, coming up in Lawsuit for Investors in shares of Aque …
A deadline is coming up on April 30, 2021in the lawsuit filed for certain investors of Aquestive Therapeutics, Inc. (NASDAQ: AQST).
Investors who purchased shares of Aquestive Therapeutics, Inc. (NASDAQ: AQST) have certain options and there are strict and short deadlines running. Deadline: April 30, 2021. NASDAQ: AQST stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint filed in the U.S. District Court…
Lawsuit filed for Investors in shares of Aquestive Therapeutics, Inc. (NASDAQ: A …
An investor, who purchased shares of Aquestive Therapeutics, Inc. (NASDAQ: AQST), filed a lawsuit over alleged violations of Federal Securities Laws by Aquestive Therapeutics, Inc.
Investors who purchased shares of Aquestive Therapeutics, Inc. (NASDAQ: AQST) have certain options and for certain investors are short and strict deadlines running. Deadline: April 30, 2021. NASDAQ: AQST investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
On December 2,…
